Published in Can J Gastroenterol on February 01, 2012
Prevalence of Helicobacter pylori and parasites in symptomatic children examined for Helicobacter pylori antibodies, antigens, and parasites in Yemen. Saudi Med J (2014) 1.14
Epidemiology of Helicobacter pylori infection among the healthy population in Iran and countries of the Eastern Mediterranean Region: a systematic review of prevalence and risk factors. World J Gastroenterol (2014) 1.02
A randomized controlled trial comparing sequential with triple therapy for Helicobacter pylori in an Aboriginal community in the Canadian North. Can J Gastroenterol (2013) 0.92
Friend and foe: factors influencing the movement of the bacterium Helicobacter pylori along the parasitism-mutualism continuum. Evol Appl (2014) 0.91
Prolonged treatment duration is required for successful Helicobacter pylori eradication with proton pump inhibitor triple therapy in Canada. Can J Gastroenterol (2013) 0.88
Prevalence of Helicobacter pylori in a First Nations population in northwestern Ontario. Can Fam Physician (2013) 0.88
Ethnicity is a strong predictor for Helicobacter pylori infection in young women in a multi-ethnic European city. J Gastroenterol Hepatol (2013) 0.86
Indigenous populations health protection: a Canadian perspective. BMC Public Health (2012) 0.82
Disease manifestations of Helicobacter pylori infection in Arctic Canada: using epidemiology to address community concerns. BMJ Open (2014) 0.80
Gastric biopsies: the gap between evidence-based medicine and daily practice in the management of gastric Helicobacter pylori infection. Can J Gastroenterol (2013) 0.80
Comparison of endoscopic based diagnosis with Helicobacter urease test for Helicobacter pylori infection. BMC Res Notes (2016) 0.77
Helicobacter pylori status among patients undergoing gastroscopy in rural northern Alberta. Can Fam Physician (2016) 0.75
What is the best regimen for Helicobacter pylori eradication in Canadian Arctic Aboriginals? Can J Gastroenterol (2013) 0.75
Helicobacter pylori and immigrant health. CMAJ (2012) 0.75
Antibiotic resistance and gyrA mutation affect the efficacy of 10-day sitafloxacin-metronidazole-esomeprazole therapy for Helicobacter pylori in penicillin allergic patients. United European Gastroenterol J (2017) 0.75
Inflammation and cancer. Nature (2002) 53.78
Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med (1991) 23.89
Helicobacter pylori infection and the development of gastric cancer. N Engl J Med (2001) 17.13
Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ (1991) 9.88
Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum (1994) 7.37
Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA (2004) 6.96
Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med (1993) 6.61
Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. Lancet (1996) 5.03
Clinical practice. Helicobacter pylori infection. N Engl J Med (2010) 4.94
Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology (1991) 4.86
Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer (2010) 4.64
Inflammation, atrophy, and gastric cancer. J Clin Invest (2007) 4.29
Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication. Ann Intern Med (2007) 3.26
Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up. Lancet (1994) 2.90
The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study. Aliment Pharmacol Ther (2003) 2.83
The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther (1995) 2.74
Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries. Dig Dis Sci (1991) 2.63
An empiric estimate of the value of life: updating the renal dialysis cost-effectiveness standard. Value Health (2009) 2.60
Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis (2000) 2.52
Helicobacter pylori infection in Canadian and related Arctic Aboriginal populations. Can J Gastroenterol (2008) 2.22
Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol (2008) 2.02
Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication. Helicobacter (2009) 2.02
Pervasive occult gastrointestinal bleeding in an Alaska native population with prevalent iron deficiency. Role of Helicobacter pylori gastritis. JAMA (1997) 1.89
Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis. Am J Gastroenterol (2006) 1.83
Helicobacter pylori cagA and vacA genotypes as predictors of progression of gastric preneoplastic lesions: a long-term follow-up in a high-risk area in Spain. Am J Gastroenterol (2011) 1.79
Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview. CMAJ (1994) 1.78
Recent developments in the epidemiology of Helicobacter pylori. Gastroenterol Clin North Am (2000) 1.72
Neglected infections of poverty among the indigenous peoples of the arctic. PLoS Negl Trop Dis (2010) 1.50
High prevalence of Helicobacter pylori in the Alaska native population and association with low serum ferritin levels in young adults. Clin Diagn Lab Immunol (2000) 1.49
Natural acquisition and spontaneous elimination of Helicobacter pylori infection: clinical implications. Am J Gastroenterol (1997) 1.48
Augmented gp130-mediated cytokine signalling accompanies human gastric cancer progression. J Pathol (2007) 1.28
Canadian Helicobacter pylori consensus conference. Canadian Association of Gastroenterology. Can J Gastroenterol (1998) 1.19
Helicobacter pylori in the Canadian arctic: seroprevalence and detection in community water samples. Am J Gastroenterol (1999) 1.16
High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication. Helicobacter (2010) 1.11
Seroprevalence of Helicobacter pylori, incidence of gastric cancer, and peptic ulcer-associated hospitalizations in a Canadian Indian population. Dig Dis Sci (1999) 1.10
Helicobacter pylori infection in Ontario: prevalence and risk factors. Can J Gastroenterol (2007) 1.08
Strategy for eliminating gastric cancer in Japan. Helicobacter (2010) 1.08
Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results. Int J Cancer (2009) 1.06
Age at acquisition of Helicobacter pylori in a pediatric Canadian First Nations population. Helicobacter (2002) 1.05
Helicobacter pylori infection in Canada's arctic: searching for the solutions. Can J Gastroenterol (2008) 1.04
Treatment of Helicobacter pylori infection 2010. Helicobacter (2010) 1.00
Gastric cancer among American Indians and Alaska Natives in the United States, 1999-2004. Cancer (2008) 0.99
Interactions between H. pylori infection, gastric acid secretion and anti-secretory therapy. Br Med Bull (1998) 0.98
Helicobacter pylori infection in different generations of Hispanics in the San Francisco Bay Area. Am J Epidemiol (2005) 0.97
Stomach cancer among New Mexico's American Indians, Hispanic whites, and non-Hispanic whites. Cancer Res (1989) 0.94
Cost-effectiveness of eradication of Helicobacter pylori in gastric cancer survivors after endoscopic resection of early gastric cancer. Helicobacter (2009) 0.93
Prevalence and persistence of antibodies to herpes viruses, Chlamydia pneumoniae and Helicobacter pylori in Alaskan Eskimos: the GOCADAN Study. Clin Microbiol Infect (2006) 0.90
Second-line rescue therapy of helicobacter pylori infection. Therap Adv Gastroenterol (2009) 0.89
Strategies for gastric cancer in the modern era. World J Gastrointest Oncol (2010) 0.87
Cost effectiveness analysis of population-based serology screening and (13)C-Urea breath test for Helicobacter pylori to prevent gastric cancer: a markov model. World J Gastroenterol (2008) 0.87
Increased cell proliferation in chronic Helicobacter pylori positive gastritis and gastric carcinoma--correlation between immuno-histochemistry and Tv image cytometry. Anal Cell Pathol (2000) 0.86
Seroepidemiology of gastritis in Japanese and Dutch male employees with and without ulcer disease. Eur J Gastroenterol Hepatol (1996) 0.83
Epidemiology of hospitalizations associated with ulcers, gastric cancers, and Helicobacter pylori infection among American Indian and Alaska Native persons. Am J Trop Med Hyg (2008) 0.83
Helicobacter pylori infection among non-Native educators in Alaska. Int J Circumpolar Health (2007) 0.83
Will eradication of Helicobacter pylori infection influence the risk of gastric cancer? Am J Med (2004) 0.83
Randomised double blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection. BMJ (1997) 0.82
Low prevalence of Helicobacter pylori infection in Canadian children: a cross-sectional analysis. Can J Gastroenterol (2008) 0.81
Response to combined molecular targeting: defining the role of P-STAT3. Clin Cancer Res (2011) 0.81
Effects of H pylori infection on gap-junctional intercellular communication and proliferation of gastric epithelial cells in vitro. World J Gastroenterol (2007) 0.80
Helicobacter pylori in a Chukotka Native male population. Int J Circumpolar Health (1998) 0.80
Helicobacter pylori infection in Greenlandic patients with dyspepsia. Int J Circumpolar Health (2004) 0.80
Helicobacter pylori and the prevention of gastric cancer. Can J Gastroenterol (2004) 0.79
Helicobacter pylori in immigrants: a "foreign" bacterium? Intern Emerg Med (2010) 0.78
Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet (2008) 15.43
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet (2009) 6.04
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet (2013) 5.58
Canadian Association of Gastroenterology and the Canadian Digestive Health Foundation: Guidelines on colon cancer screening. Can J Gastroenterol (2004) 5.09
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Lancet (2003) 4.27
Multiple loci on 8q24 associated with prostate cancer susceptibility. Nat Genet (2009) 3.94
Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol (2009) 3.88
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet (2011) 3.07
Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol (2004) 2.86
The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): Endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real-life setting. Am J Gastroenterol (2004) 2.80
Optimum duration of regimens for Helicobacter pylori eradication. Cochrane Database Syst Rev (2013) 2.53
Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004. Can J Gastroenterol (2005) 2.36
Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol (2008) 2.28
Predicting the probability of deferred radical treatment for localised prostate cancer managed by active surveillance. Eur Urol (2008) 2.25
Host susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentium. Infect Immun (2003) 2.17
Diffusion-based tractography in neurological disorders: concepts, applications, and future developments. Lancet Neurol (2008) 2.13
Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol (2005) 2.10
Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol (2008) 2.02
A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study. Am J Gastroenterol (2005) 1.94
Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer. BJU Int (2008) 1.88
Inflammatory bowel disease in the South Asian pediatric population of British Columbia. Am J Gastroenterol (2007) 1.88
Setting a research agenda for progressive multiple sclerosis: the International Collaborative on Progressive MS. Mult Scler (2012) 1.75
Canadian Helicobacter Study Group Consensus Conference: Update on the management of Helicobacter pylori--an evidence-based evaluation of six topics relevant to clinical outcomes in patients evaluated for H pylori infection. Can J Gastroenterol (2004) 1.59
Helicobacter pylori eradication for the prevention of gastric neoplasia. Cochrane Database Syst Rev (2015) 1.58
Cost-effectiveness of proton-pump inhibition before endoscopy in upper gastrointestinal bleeding. Clin Gastroenterol Hepatol (2008) 1.56
Detection of TMPRSS2-ERG translocations in human prostate cancer by expression profiling using GeneChip Human Exon 1.0 ST arrays. J Mol Diagn (2007) 1.55
Commonly used preparations for colonoscopy: efficacy, tolerability, and safety--a Canadian Association of Gastroenterology position paper. Can J Gastroenterol (2006) 1.49
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Hum Mol Genet (2012) 1.47
The cost of an upper gastroduodenal endoscopy: an activity-based approach. Can J Gastroenterol (2002) 1.46
Reproducibility of retinal circulation measurements obtained using laser speckle flowgraphy-NAVI in patients with glaucoma. Clin Ophthalmol (2011) 1.40
Persistent elevated tissue-transglutaminase in cystic fibrosis. J Paediatr Child Health (2009) 1.39
Survey of access to gastroenterology in Canada: the SAGE wait times program. Can J Gastroenterol (2010) 1.37
A randomized trial of yoga for adolescents with irritable bowel syndrome. Pain Res Manag (2006) 1.35
Citrobacter rodentium infection causes both mitochondrial dysfunction and intestinal epithelial barrier disruption in vivo: role of mitochondrial associated protein (Map). Cell Microbiol (2006) 1.35
MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters. AJR Am J Roentgenol (2009) 1.32
Isolation and genotyping of Helicobacter pylori from untreated municipal wastewater. Appl Environ Microbiol (2002) 1.32
Modulation of inducible nitric oxide synthase expression by the attaching and effacing bacterial pathogen citrobacter rodentium in infected mice. Infect Immun (2002) 1.29
Multiple sclerosis in the UK: service use, costs, quality of life and disability. Pharmacoeconomics (2008) 1.28
Positron emission tomography in the investigation of pediatric inflammatory bowel disease. Inflamm Bowel Dis (2005) 1.18
Clinically isolated syndromes suggestive of multiple sclerosis, part 2: non-conventional MRI, recovery processes, and management. Lancet Neurol (2005) 1.17
Canadian Helicobacter Study Group Consensus Conference: Update on the approach to Helicobacter pylori infection in children and adolescents--an evidence-based evaluation. Can J Gastroenterol (2005) 1.17
Spinal-cord MRI in multiple sclerosis. Lancet Neurol (2003) 1.15
Propofol use for sedation during endoscopy in adults: a Canadian Association of Gastroenterology position statement. Can J Gastroenterol (2008) 1.15
The patient's experience of being a human subject. J R Soc Med (2008) 1.15
Significant correlations between optic nerve head microcirculation and visual field defects and nerve fiber layer loss in glaucoma patients with myopic glaucomatous disk. Clin Ophthalmol (2011) 1.14
Recovery after spinal cord relapse in multiple sclerosis is predicted by radial diffusivity. Mult Scler (2010) 1.14
Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin. Clin Gastroenterol Hepatol (2006) 1.13
Prevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategies. Ann Med (2006) 1.11
Impact on clinical and cost outcomes of a centralized approach to acute stroke care in London: a comparative effectiveness before and after model. PLoS One (2013) 1.11
A Canadian clinical practice algorithm for the management of patients with nonvariceal upper gastrointestinal bleeding. Can J Gastroenterol (2004) 1.10
A three-year, multi-parametric MRI study in patients at presentation with CIS. J Neurol (2008) 1.07
Predicting which patients can undergo upper endoscopy comfortably without conscious sedation. Gastrointest Endosc (2002) 1.07
Fractures around the lateral cortical hinge after a medial opening-wedge high tibial osteotomy: a new classification of lateral hinge fracture. Arthroscopy (2011) 1.05
Esomeprazole 40 mg once a day in patients with functional dyspepsia: the randomized, placebo-controlled "ENTER" trial. Am J Gastroenterol (2006) 1.04
Helicobacter pylori infection in Canada's arctic: searching for the solutions. Can J Gastroenterol (2008) 1.04
Loss of single immunoglobulin interlukin-1 receptor-related molecule leads to enhanced colonic polyposis in Apc(min) mice. Gastroenterology (2010) 1.04
Management of patients with nonvariceal upper gastrointestinal bleeding. Clin Gastroenterol Hepatol (2011) 1.03
Evidence-based recommendations for short- and long-term management of uninvestigated dyspepsia in primary care: an update of the Canadian Dyspepsia Working Group (CanDys) clinical management tool. Can J Gastroenterol (2005) 1.01
Perinatal lipid nutrition alters early intestinal development and programs the response to experimental colitis in young adult rats. Am J Physiol Gastrointest Liver Physiol (2010) 1.00
Predictors of histological disease progression in untreated, localized prostate cancer. J Urol (2007) 1.00
Home versus outpatient administration of intravenous steroids for multiple-sclerosis relapses: a randomised controlled trial. Lancet Neurol (2006) 0.99
The impact of illness in patients with moderate to severe gastro-esophageal reflux disease. BMC Gastroenterol (2005) 0.97
European validation of a standardized clinical description of multiple sclerosis. J Neurol (2004) 0.96
Prostate-specific antigen (PSA) kinetics in untreated, localized prostate cancer: PSA velocity vs PSA doubling time. BJU Int (2008) 0.96
Novel approaches to inhibition of gastric acid secretion. Curr Gastroenterol Rep (2010) 0.96
Developing the ICF Core Sets for multiple sclerosis to specify functioning. Mult Scler (2007) 0.95
Active vitamin D (1,25-dihydroxyvitamin D3) increases host susceptibility to Citrobacter rodentium by suppressing mucosal Th17 responses. Am J Physiol Gastrointest Liver Physiol (2012) 0.95
The congenital intrahepatic arterioportal fistula syndrome: elucidation and proposed classification. J Pediatr Gastroenterol Nutr (2006) 0.94
Tracking changes following spinal cord injury: insights from neuroimaging. Neuroscientist (2012) 0.94
Myenteric plexus injury and apoptosis in experimental colitis. Auton Neurosci (2005) 0.94
Comparison of multidetector CT and barium studies of the small bowel: inflammatory bowel disease in children. AJR Am J Roentgenol (2003) 0.93
Esophageal Crohn disease in children: a clinical spectrum. J Pediatr Gastroenterol Nutr (2003) 0.92
The normal post-surgical anatomy of the male pelvis following radical prostatectomy as assessed by magnetic resonance imaging. Eur Radiol (2008) 0.91
Predicting progression in primary progressive multiple sclerosis: a 10-year multicenter study. Ann Neurol (2008) 0.91
A matched cohort study of feeding practice guidelines for infants weighing less than 1,500 g. Adv Neonatal Care (2002) 0.89
Cyclooxygenase-2 inhibitors in colorectal cancer prevention: counterpoint. Cancer Epidemiol Biomarkers Prev (2008) 0.89
Longitudinal evaluation of clinically early relapsing-remitting multiple sclerosis with diffusion tensor imaging. J Neurol (2008) 0.88
The influence of demographic factors and health-related quality of life on treatment satisfaction in patients with gastroesophageal reflux disease treated with esomeprazole. Health Qual Life Outcomes (2005) 0.88
Dietary oils modify the host immune response and colonic tissue damage following Citrobacter rodentium infection in mice. Am J Physiol Gastrointest Liver Physiol (2013) 0.88
A randomized multicenter trial to evaluate simple utility elicitation techniques in patients with gastroesophageal reflux disease. Med Care (2004) 0.88
Dissecting structure-function interactions in acute optic neuritis to investigate neuroplasticity. Hum Brain Mapp (2010) 0.88
Effect of topical tafluprost on optic nerve head blood flow in patients with myopic disc type. J Glaucoma (2013) 0.88
Canadian pediatric gastroenterology workforce: current status, concerns and future projections. Can J Gastroenterol (2007) 0.87
Esophageal candidiasis in an immunocompetent girl. World J Pediatr (2009) 0.87
Population structure of Anopheles arabiensis on La Réunion island, Indian Ocean. Am J Trop Med Hyg (2005) 0.87
Adolescent and adult children of parents with Parkinson's disease: incorporating their needs in clinical guidelines. Parkinsons Dis (2011) 0.87
Say goodbye and say hello: the transition from pediatric to adult gastroenterology. Can J Gastroenterol (2004) 0.87
SHIP-deficient mice develop spontaneous intestinal inflammation and arginase-dependent fibrosis. Am J Pathol (2011) 0.86
Canadian Association of Gastroenterology position statement: fecal microbiota transplant therapy. Can J Gastroenterol Hepatol (2014) 0.85
The Work Productivity and Activity Impairment Questionnaire for Patients with Gastroesophageal Reflux Disease (WPAI-GERD): responsiveness to change and English language validation. Pharmacoeconomics (2007) 0.85
Identification of new genetic risk factors for prostate cancer. Asian J Androl (2008) 0.85
Differential responses of VIPergic and nitrergic neurons in paediatric patients with Crohn's disease. Auton Neurosci (2007) 0.85
Noradrenergic and cholinergic neural pathways mediate stress-induced reactivation of colitis in the rat. Auton Neurosci (2006) 0.84
Evidence-based feeding guidelines for very low-birth-weight infants. Adv Neonatal Care (2002) 0.84
Prehospital triage of acute myocardial infarction: wireless transmission of electrocardiograms to the on-call cardiologist via a handheld computer. J Electrocardiol (2005) 0.84
Analysis of the population structure of Anopheles funestus (Diptera: Culicidae) from western and coastal Kenya using paracentric chromosomal inversion frequencies. J Med Entomol (2002) 0.84
Generation of 3D retina-like structures from a human retinal cell line in a NASA bioreactor. Cell Transplant (2003) 0.83